Risk-based redesign of internal quality control procedures for emergency immunoassays in clinical laboratories: a multicenter study from China.

Authors

Guangjun Xiao, Juan Hu, Yanting Liu, Sihan Zhao, Weifeng Liao, Huanhuan Wang, Shaocheng Zhang

Published in

Frontiers in medicine. Volume 13. Pages 1906788. Epub Jul 27, 2026.

Abstract

Although clinical laboratories routinely implement internal quality control (IQC) to ensure the reliability of test results, emergency immunoassay testing introduces unique operational challenges. To mitigate financial burdens, some laboratories arbitrarily extend IQC batch lengths or reduce the number of quality control (QC) samples per analytical run. This study evaluated baseline IQC practices for emergency immunoassays across five laboratories in Suining, China, aiming to provide evidence-based guidance for regional quality improvement.
Average daily test volumes, external quality assessment (EQA) results, and historical IQC data were retrospectively collected from the five laboratories. Sigma metrics were calculated for each analyte. Concurrently, the "Westgard Sigma Rule with Run Length" nomogram was applied to design individualized, risk-based statistical quality control (RB-SQC) procedures.
All emergency immunoassays, except for serum procalcitonin, were subjected to routine IQC across all five laboratories; notably, certain analytes followed an extended 72-h IQC batch interval. Within individual laboratories, QC rules, the number of QC results per batch, and batch lengths were consistent across analytes but varied between laboratories. Under the current QC scheme, the QC utilization rate (N/M-1) was 0.087 (0.047-0.143), which decreased significantly to 0.020 (0.004-0.133) after implementing RB-SQC procedures (N/M-2; Z = 3.154, P < 0.05), suggesting that RB-SQC may reduce QC material and reagent consumption while maintaining acceptable patient risk. However, arbitrary adjustments to batch lengths or the number of QC results may lead to elevated or reduced QC utilization rates.
Baseline IQC practices for emergency immunoassays in the surveyed laboratories were inconsistent and lacked a standardized risk-based foundation. We recommend that clinical laboratories implement individualized RB-SQC protocols designed using the Westgard Sigma Rule with Run Length nomogram, and periodically reassess their appropriateness based on updated sigma metrics.

PMID:
42577278
Bibliographic data and abstract were imported from PubMed on 11 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.